Taiwan Liposome Company, Ltd. TLC
$ 7.0
0.0%
Country |
Taiwan |
IPO year |
2018 |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Keelung Hong |
Employees in the company |
- |
Shares |
32.9 M |
Market Cap[1] |
$ 303 M |
EBITDA (LTM) |
$ 767 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.